Syngenta announced today that Robert Berendes, Head Business Development, will be leaving the company at the end of the first quarter to become co-owner and partner of a-connect, the global consulting firm specializing in strategy implementation, growth projects and change management. Robert joined Syngenta in 2002 from McKinsey & Company where he was a partner, and became a member of the Syngenta Executive Committee in 2007.
Mike Mack, Syngenta CEO said: “I should like to thank Robert for his outstanding contributions to Syngenta over the past 11 years, including most recently his ad interim leadership of R&D for the last 14 months. On behalf of the Executive Committee, I wish him every success in his new endeavor.”
Further information on a-connect and Robert Berendes is available here.
Syngenta is one of the world's leading companies with more than 27,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.